Literature DB >> 15562675

Portal systemic encephalopathy.

S Schenker1, M K Bay.   

Abstract

The goal of this article is to update the status of Portal systemic encephalopathy (PSE) in the light of new data. First, PSE is the context of other types of hepatic encephalopathy. Subsequently, current views of the pathogenesis of the disorder are discussed, followed by an analysis of therapeutic options. Diagnosis will not be considered, as no major new developments have recently been documented in this area.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 15562675     DOI: 10.1016/s1089-3261(05)70262-2

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  3 in total

1.  Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.

Authors:  D W Y Ho; S T Fan; J To; Y H Woo; Z Zhang; C Lau; J Wong
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.

Authors:  Miguel R Arguedas; Thomas G DeLawrence; Brendan M McGuire
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

3.  Case Report: A Rare Syncope Case Caused by Abernethy II and a Review of the Literature.

Authors:  Xue-Qin Lin; Jing-Yi Rao; Yi-Fei Xiang; Li-Wei Zhang; Xiao-Ling Cai; Yan-Song Guo; Kai-Yang Lin
Journal:  Front Cardiovasc Med       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.